Gujarat Inject Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
For the nine months, sales was INR 1.74 million compared to INR 0.226 million a year ago. Revenue was INR 5.76 million compared to INR 0.278 million a year ago. Net income was INR 0.35 million compared to net loss of INR 0.313 million a year ago. Basic earnings per share from continuing operations was INR 0.07 compared to basic loss per share from continuing operations of INR 0.06 a year ago. Diluted earnings per share from continuing operations was INR 0.07 compared to diluted loss per share from continuing operations of INR 0.06 a year ago.